Synthesis, DNA binding, docking and photoclevage studies of novel benzo[b][1,8]naphthyridines

Medicinal Chemistry

Volumn 5, Issue 5, 2009, Pages 411-418

  Naik, T R Ravikumar ^a   Naik, H S Bhojya ^a   Naik, H R Prakash ^a   Bindu, P J ^a   Harish, B G ^a   Krishna, V ^a  

^a KUVEMPU UNIVERSITY   (India)

Author keywords

Benzo b 1,8 naphthyridines; DNA minor groove; Docking studies; Photoclevage; Synthesis

Indexed keywords

3 IODOBENZO[B][1,8]NAPHTHYRIDIN 5 (5AH)ONE; 3 IODOBENZO[B][1,8]NAPHTHYRIDINE 5 THIOL; 3 METHYLBENZO[B][1,8]NAPHTHYRIDIN 5 (5AH)ONE; 3 METHYLBENZO[B][1,8]NAPHTHYRIDINE 5 THIOL; 5 CHLORO 3 IODOBENZO[B][1,8]NAPHTHYRIDINE; 5 CHLORO 3 METHYLBENZO[B][1,8]NAPHTHYRIDINE; 5 CHLOROBENZO[B][1,8]NAPHTHYRIDINE; BENZO[B][1,8]NAPHTHYRIDIN 5 (5AH)ONE; BENZO[B][1,8]NAPHTHYRIDINE 5 THIOL; BENZO[B][1,8]NAPHTHYRIDINE DERIVATIVE; DOUBLE STRANDED DNA; NAPHTHYRIDINE DERIVATIVE; PLASMID DNA; UNCLASSIFIED DRUG;

ARTICLE; AT RICH SEQUENCE; BINDING AFFINITY; CONTROLLED STUDY; DNA CLEAVAGE; DRUG DNA BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; MOLECULAR DOCKING; PRIORITY JOURNAL;

ABSORPTION; BASE SEQUENCE; DEOXYRIBONUCLEASES; DNA; DRUG DESIGN; GREEN CHEMISTRY TECHNOLOGY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NAPHTHYRIDINES; PHOTOLYSIS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 70349148667     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340609789117804     Document Type: Article

References (33)

1. For reviews of recent efforts to improve antracyclines see (a) Monneret, C. Recent developments in the field of antitumour anthracyclines. Eur. J. Med. Chem., 2001, 36(6), 483-493.
2. (b) Minotti, G.; Menna, P.; Salvatorelli, E.; Cairo, G.; Gianni, L. The anthracyclines: Molecular advances and pharmacological developments in antitumor activity and cardiotoxicity. Pharmacol. Rev., 2004, 56, 185-229.
3. Trail, P. A.; Willner, D.; Lasch, S. J.; Henderson, A. J.; Hofstead, S.; Casazza, A. M.; Firestone, R. A.; Hellstrom, I.; Hellstrom, K. E. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science 1993, 261, 212-215.
4. Smolina, I. V.; Demidov, V. V.; Frank-Kamenetskii, M. D. Pausing of DNA polymerases on duplex DNA templates due to ligand binding in vitro. J. Mol. Biol., 2003, 326 (4), 1113-1125.
5. Bonnet, R. Chemical Aspects of Photodynamic Therapy. Gordon and Breach: London, U.K., 2000
6. Henderson, B. W.; Busch, T. M.; Vaughan, L. A.; Frawley, N. P.; Babich, D.; Sosa, T. A.; Zollo, J. D.; Dee, A. S.; Cooper, M. T.; Bellnier, D. A.; Greco, W. R.; Oseroff, A. R. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer. Res., 2000, 60, 525-529
7. Sternberg, E. D.; Dolphin, D.; Bruckner, C. Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron, 1998, 54, 4151-4202
8. Ali, H.; Van Lier, J. E. Metal complexes as photo- and radiosensitizers. Chem Rev., 1999, 99, 2379-2450.
9. Armitage, B. Photocleavage of nucleic acids. Chem. Rev., 1998, 98, 1171-1200
10. Demeunynck, M.; Bailly, C.; Wilson, W. D., Eds.; DNA and RNA Binders; Wiley-VCH: Weinheim, 2002
11. Wilson, W.D. Nucleic Acids in Chemistry and Biology; Blackburn, G. M.; Gait, M. J. Eds.; IRL Press: Oxford, U. K., 1996, p. 329
12. Ihmels, H.; Faulhaber, K.; Viola, G. Highlights in Bioorganic Chemistry: Methods and Applications; Schmuck, C.; Wennemers, H., Eds. Wiley-VCH: Weinheim, 2004.
13. Canti, G.; De Simone, A.; Korbelik, M. Photodynamic therapy and the immune system in experimental oncology. Photochem. Photobiol. Sci., 2002, 1, 79-80
14. Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst. 1998, 90, 889-902.
15. Randic, M. Novel graph theoretical approach to heteroatoms in quantitative structure-activity relationship. Chemometr. Intel. Lab. Syst., 1991, 10, 213-227.
16. Rege, K.; Ladiwala, A.; Hu, S.; Breneman, C. M.; Dordick, J. S.; Cramer, S. M. Investigation of DNA-binding properties of an aminoglycoside-polyamine library using quantitative structure - activity relationship (QSAR) models. J. Chem. Inf. Model., 2005, 45 (6), 1854-1863
17. Patrizia, D.; Annamaria, M.; Paola, B.; Antonino, L.; Alessandra, M.; Anna, M. A.; Gaetano, D.; Girolamo, C. Isoindolo[2,1-c] benzo[1,2,4]triazines: A new ring system with antiproliferative activity. Bioorg. Med. Chem., 2007, 15, 343-349.
18. Srinivas, O.; Praveen, K, S.; Kasey, R.; Kohei, Y.; Christophe, L.M.J.V.; Debopam, C.; Wesley, C.V.V.; Michael, H.G. 2-Oxotetrahydro-1,8-naphthyridines as selective inhibitors of malarial protein farnesyltransferase and as anti-malarials. Bioorg. Med. Chem. Letts., 2008, 18, 494-497.
19. Marchese, A.; Debbia, E. A.; Schito, G. C. Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project. J. Antimicrob. Chemother., 2000, 46, 11-15.
20. Ferrarini, P. L.; Mori, C.; Tellini, N. Synthesis and local anesthetic activity of (E)- and (Z)-diethylaminoethyliminothers of 1,8-naphtyridine. Farmaco., 1990, 45(3), 385-389.
21. Lirvinov, V. P. Advances in the chemistry of naphthyridines. Adv. Heterocycl. Chem., 2006, 189-273.
22. Mekheimer, R.A.; Abdel Hameed, A.M.; Sadek, K.U. 1,8-Naphthyridines II: synthesis of novel polyfunctionally substituted 1,8-naphthyridinones and their degradation to 6-aminopyridones. ARKIVOC., 2007, ( xiii), 269-281.
23. Ferrarini, P. L.; Badawneh, M.; Franconi, F.; Manera, C.; Miceli, M.; Mori, C.; Saccomanni, G. Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives. Farmaco., 2001, 56, 311-318.
24. Badawneh, M.; Ferrarini, P. L.; Calderone, V.; Manera, C.; Martinotti, E.; Mori, C.; Saccomanni, G.; Testai, L. Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X. Eur. J. Med. Chem., 2001, 36, 925-934.
25. Ferrarini, P. L.; Manera, C.; Mori, C.; Badawneh, M.; Saccomanni, G. Synthesis and evaluation of antimycobacterial activity of 4-phenyl-1,8-naphthyridine derivatives. Farmaco., 1998, 53, 741-746.
26. 2O catalyzed multi component one-pot synthesis of novel Naphthyridines. Mol. Divers., 2008, 12, 139-142.
27. Ravikumar, N. T. R.; Bhojya, N. H. S.; Raghavendra, M.; Gopalkrishna, N. S. R. Synthesis of thieno[2,3-b]benzo[1,8] naphthyridine-2-carboxylic acids undermicrowave irradiation and interaction with DNA studies. ARKIVOC, 2006, xv, 84-94.
28. Waring, M. J.; Roberts, G. C. K., Eds.; Drug Action at the Molecular Level, Maemillar, London, 1977, p. 167.
29. Sun, C.; Aspland, S. E.; Ballatore, C.; Castillo, R.; Smith, A. B.; Castellino, A. J. The design, synthesis, and evaluation of two universal doxorubicin-linkers: Preparation of conjugates that retain topoisomerase II activity. Bio. Org. Med. Chem. Letts., 2006, 16, 104-107.
30. Ghose, A.K.; Crippen, G.M. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships III: Modeling hydrophobic interactions. J. Chem. Inform. Comput. Sci., 1988, 9, 80-90.
31. Weiner, S.J.; Kollman, P.A.; Case, D.A.; Singh, U.C.; Ghio, C.; Alagona, G.; Profeta, S.; Jr. Weiner, P.K. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc., 1984, 106, 765-784.
32. Gasteiger, J., Marsili, M. Iterative partial equalization of orbital electronegativity a rapid access to atomic charges. Tetrahedron, 1980, 36, 3219-3228.
33. Mehler, E.L.; Solmajer, T. Electrostatic effects in proteins comparison of dielectric and charge models. Prot. Eng. 1991, 4, 903-910.